Interestingly, adiponectin was also found to be an independent predictor of T2D development and subsequently CV risk, as high plasma adiponectin was associated with a decreased risk of suffering a CV event among a population with T2D (41). Here, ADIPOQ is linked to type 2 diabetes mellitus.